Compass Therapeutics, Inc.

NASDAQ:CMPX

Biotechnology

Healthcare
$0.61 -1.46%

-$0.03 today

Market cap
$109.26M
Beta
0.74
P/E (TTM)
-5.5
EPS (TTM)
-$0.37
52W Low $1.61High $6.88

Volume 2.90M

Average 7.64M

Balance Sheet

Inspect the capital base behind the business.

Assets

$219.59M

FY 2025 · Annual

+56.4% YoY

Liabilities

$22.80M

FY 2025 · Annual

+50.3% YoY

Equity

$196.79M

FY 2025 · Annual

+57.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents144.51M34.95M24.23M43.48M30.64M
Short-term Investments0151.66M128.23M83.24M178.26M
Net Receivables00000
Inventory00000
Other Current Assets08.18M1.42M6.03M913K
Total Current Assets147.11M194.79M153.88M132.75M209.82M
Property, Plant & Equipment (Net)6.33M4.53M2.67M7.08M9.2M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets320K320K320K568K568K
Total Non-current Assets6.65M4.85M2.99M7.65M9.77M
Total Assets153.76M199.65M156.88M140.4M219.59M
Account Payables867K3.38M4.09M2.25M1.59M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.6M1.56M1.94M2.79M2.68M
Total Current Liabilities10.63M16.17M7.8M8.87M13.97M
Long-term Debt00008.83M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0001K0
Total Non-current Liabilities3.05M1.84M536K6.3M8.83M
Total Liabilities13.68M18.01M8.34M15.17M22.8M
Common Stock10K13K13K13K18K
Retained Earnings(233.59M)(272.81M)(315.31M)(364.68M)(431.17M)
Accumulated OCI0(302K)37K210K280K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity140.08M181.64M148.54M125.23M196.79M
Total Debt4.04M2.94M1.73M6.63M9.83M
Net Debt(140.48M)(32.01M)(22.5M)(36.85M)(20.81M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$55.2M
Short-term Investments$139.5M
Other Current$1.0M
Total Current Assets$195.7M
PP&E (Net)$8.9M
Other Non-current$568.0K
Total Non-current Assets$9.5M
Total Assets$205.2M

Analysis

Selected assets total $205.2M for Latest. The largest visible component is Short-term Investments at $139.5M, about 68.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipSep 25, 2026

How much cash does CMPX have?

Compass Therapeutics, Inc. (CMPX) reported $30.64M in cash and equivalents in fiscal 2025.

How much debt does CMPX carry?

Compass Therapeutics, Inc. (CMPX) reported $9.83M of total debt, with net debt of -$20.81M.